Category: Treatment News
Personalized Medicine for Mesothelioma Patients Gets Boost From the FDA
The U.S. Food and Drug Administration is undertaking “unique responsibilities” in facilitating the advancement of personalized medicine. This is bound to help mesothelioma patients as researchers focus on identifying biomarkers unique to mesothelioma.
Label: Treatment NewsPosted on Monday, Nov 18, 2013
CDC Suggests Consulting with Infectious Disease Specialists for Treating Mesothelioma Patients with Infections
Mesothelioma patients are susceptible to infections that can lead to life-threatening complications. In a recent blog article on the U.S. CDC’s Safe Healthcare site, Dr. Steven Schmitt suggests including infectious disease specialists in the treatment of patients.
Label: Treatment NewsPosted on Friday, Nov 8, 2013
FDA’s Approval of Afatinib for Lung Cancer Brings New Treatment Option to Mesothelioma Patients
In January, the U.S. Food and Drug Administration granted priority status to the anti-cancer compound Gilotrif (afatinib). Now, the FDA has granted approval to the drug for patients with late stage non-small cell lung cancer whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. The …
Label: Treatment NewsPosted on Thursday, Jul 18, 2013